Pulmonary arterial hypertension: classification, diagnosis and contemporary management.
作者信息
Fox D J, Khattar R S
机构信息
Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
出版信息
Postgrad Med J. 2006 Nov;82(973):717-22. doi: 10.1136/pgmj.2006.044941.
Abstract
摘要
相似文献
1
Pulmonary arterial hypertension: classification, diagnosis and contemporary management.肺动脉高压：分类、诊断与现代治疗
Postgrad Med J. 2006 Nov;82(973):717-22. doi: 10.1136/pgmj.2006.044941.
2
Therapy for pulmonary arterial hypertension associated with systemic sclerosis.系统性硬皮病相关肺动脉高压的治疗。
Curr Opin Rheumatol. 2009 Nov;21(6):642-8. doi: 10.1097/BOR.0b013e3283307dc8.
3
Medical therapy for pulmonary arterial hypertension.肺动脉高压的药物治疗。
Expert Opin Pharmacother. 2008 Jan;9(1):65-81. doi: 10.1517/14656566.9.1.65.
4
Pulmonary hypertension in older children: new approaches and therapies.大龄儿童肺动脉高压：新方法与治疗手段
Paediatr Respir Rev. 2006;7 Suppl 1:S177-9. doi: 10.1016/j.prrv.2006.04.210. Epub 2006 Jun 5.
5
[Treatment of pulmonary hypertension associated with connective tissue disease].[结缔组织病相关肺动脉高压的治疗]
Nihon Rinsho Meneki Gakkai Kaishi. 2008 Dec;31(6):424-31. doi: 10.2177/jsci.31.424.
6
Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
Prog Cardiovasc Nurs. 2004 Spring;19(2):74-9. doi: 10.1111/j.0889-7204.2004.02898.x.
7
[Eisenmenger syndrome. Specific treatments].[艾森曼格综合征。特异性治疗]
Presse Med. 2009 Dec;38 Suppl 1:1S18-22. doi: 10.1016/S0755-4982(09)73420-7.
8
Portopulmonary hypertension.门肺高压
Clin Liver Dis. 2006 Aug;10(3):653-63, x. doi: 10.1016/j.cld.2006.08.023.
9
Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension.成人先天性心脏病相关肺动脉高压的治疗方法。
Eur Respir Rev. 2010 Dec;19(118):300-7. doi: 10.1183/09059180.00004510.
10
Improving care for patients with pulmonary hypertension: comment on "Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study".改善肺动脉高压患者的护理：对“肺动脉高压诊断患者转诊至三级肺动脉高压中心：多中心RePHerral研究”的评论
JAMA Intern Med. 2013 May 27;173(10):893. doi: 10.1001/jamainternmed.2013.783.
引用本文的文献
1
Patient-specific finite element analysis of heart failure and the impact of surgical intervention in pulmonary hypertension secondary to mitral valve disease.基于个体患者的心力衰竭有限元分析及其对二尖瓣病变继发肺动脉高压手术干预的影响。
Med Biol Eng Comput. 2022 Jun;60(6):1723-1744. doi: 10.1007/s11517-022-02556-6. Epub 2022 Apr 20.
2
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.肺动脉高压——系统性硬化症的致命并发症
J Clin Rheumatol Musculoskelet Med. 2010 Dec 1;1(2):11-20.
本文引用的文献
1
Pulmonary arterial hypertension.肺动脉高压
N Engl J Med. 2004 Oct 14;351(16):1655-65. doi: 10.1056/NEJMra035488.
2
Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
Chest. 2004 Jul;126(1 Suppl):63S-71S. doi: 10.1378/chest.126.1_suppl.63S.
3
Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.肺动脉高压的诊断与管理：美国胸科医师学会循证临床实践指南
Chest. 2004 Jul;126(1 Suppl):4S-6S. doi: 10.1378/chest.126.1_suppl.4S.
4
Clinical classification of pulmonary hypertension.肺动脉高压的临床分类
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S. doi: 10.1016/j.jacc.2004.02.037.
5
Sitaxsentan therapy for pulmonary arterial hypertension.西他生坦治疗肺动脉高压
Am J Respir Crit Care Med. 2004 Feb 15;169(4):441-7. doi: 10.1164/rccm.200307-957OC. Epub 2003 Nov 20.
6
Beraprost therapy for pulmonary arterial hypertension.贝前列素治疗肺动脉高压
J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25. doi: 10.1016/s0735-1097(03)00463-7.
7
Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.在肺动脉高压患者中，除持续静脉输注依前列醇外，加用口服西地那非进行长期治疗。
Chest. 2003 Apr;123(4):1293-5. doi: 10.1378/chest.123.4.1293.
8
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9. doi: 10.1097/00005344-200302000-00019.
9
A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.
Indian Heart J. 2002 Jul-Aug;54(4):410-4.
10
Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.原发性肺动脉高压的生存率：依前列醇治疗的影响。
Circulation. 2002 Sep 17;106(12):1477-82. doi: 10.1161/01.cir.0000029100.82385.58.
Zotero 插件